Does data prove that the "low" jobs additions in April '21 is due to extended unemployment benefits?

 The U.S. Chamber of Commerce tweeted that the extended unemployment benefits should be stopped given the "low" number of job additions during April 2021.

“The disappointing jobs report makes it clear that paying people not to work is dampening what should be a stronger jobs market."

See the full statement from our EVP @NeilBradleyDC on this morning's @BLS_gov jobs report: https://t.co/uE1557IKt3 pic.twitter.com/HIeDFwoZb5

— U.S. Chamber (@USChamber) May 7, 2021

There's lot of chatter that people are getting more in unemployment benefits and that's keeping them from taking a job. April saw addition of 266,000 jobs. In a normal economy, 266,000 jobs would be a very good report. There could be multiple reasons for why the jobs report came in well below the expectation of a 1 million jobs. 

• Many parents still have kids who are remote learning. So, they may not have the flexibility to take-up employment while they are caring for their kids.    
• Vaccines were only widely available in the middle of April. So, people who were waiting to get vaccinated before heading to work, can only now get fully vaccinated.  

The best response to US Chamber of Commerce was provided by Ben Zipperer:

Hard to single out unemployment benefits as "dampening" job growth in the lowest-wage industries when those same industries are the ones with the fastest job growth https://t.co/4OqlLBc7PW pic.twitter.com/EjXJI7aswl

— Ben Zipperer (@benzipperer) May 7, 2021

        

Equinix: Technical Set-up Looks Good

 Equinix (EQIX):

EQIX has been on BofA US 1 list for a long time. It seemed to be very expensive, finally it has come back down and I have opened a position today at $640. Actually, I wish I had picked it up yesterday.

$EQIX's Technical Set-up 

1. Trading near the bottom of the bollinger bands
2. Money Flow Indicator flashing oversold
3. RSI just coming-off of oversold territory.  
4. On-balance Volume is negative indicating oversold

Exhibit: Equinix Technical Indicators

(Source: E*Trade)

I am going to buy Total S.E. (NYSE: TOT) on any short-term weakness

Total S.E. is on Bank of America's Top Rated Stocks list. When I saw that name, I was intrigued. Why is an oil giant from Europe on this list? I have done my research and found out that they have a growing green energy portfolio for which they are not getting much credit now.  I am going to buy on any short-term weakness (below $45 may be a start) and put it away for a long time and keep collecting the dividend (6.6%).

(Source: Google)

Bank of America Adds AES Corp to US1, Removes Ameren Corp.

On August 13, 2020, Bank of America added AES Corp., (NYSE: AES) to its US-1 List. According to the bank, the US 1 list is the collection of the their best investment ideas that is subset of their buy-rated stocks. The bank has now removed Ameren (NYSE: AEE) from that list.

AES has had a huge run since May 11, 2020. It has risen from $11.87 on May 11 to $17.67 on August 17. That's a 49% gain in three months.  It may be wise to wait for a pull back before adding the stock to your portfolio.  A good entry point may be around $14.39. Currently, the money flow indicator is in overbought territory and the stock is hugging the upper part of the Bollinger Bands.  

Exhibit: AES Corp., has had a huge run 

 (Source: Tradingview)        

Disclosure: I do not own AES or Ameren

Barron's Recommends Merck, But Is it a Buy At $83.

Barron's has recommended Merck (NYSE: MRK) stating that the company does not get "enough credit". Merck is currently trading at $83.48. The price is currently hugging the upper part of the Bollinger Band. The money flow indicator is approaching over-bought territory and currently sits at 60. The MACD is flashing a buy signal. All the moving averages are currently flashing a buy. If there's any pullback, the stock may be a buy at $75 or $76.  

Exhibit: Merck May Be a Buy at $75 or $76.

 

(Source: Tradingview)

 

Exhibit: Merck Moving Averages Are Indicating a Buy

 (Source: Tradingview)

Exhibit: Merck Oscillators

 

 

(Source: Tradingview)          

Large Insider Buy at Pfizer Made Me Look At that Stock

Barron's has reported that Pfizer's Director Ronald Blaylock has made the largest open-market purchase of the stock since 2003. Mr. Blaylock paid $510,000 on August 6th for 13,000 Pfizer (NYSE: PFE) shares. The Director has paid an average price of $38.53 for the shares. The stock has been trading lower and as of Friday, August 14, 2020, it was trading at $38.06. The money flow indicator is nearing oversold territory and the MACD is flashing a sell signal. A good entry point for the stock may be around $37.70. There seems to be support for the stock at this level. If the stock breaks below $37, another entry point would be around $32.50. The stock was at that level when the money flow indicator was in oversold territory on July 24, 2020.

Exhibit: Entry Points for Pfizer 

 

 (Source: Tradingview)           

Exited my position in Redfin and Energy Recovery

I had written about Energy Recovery Inc., (NASDAQ: ERII) on my blog on July 25, 2020. I had taken a small position in Energy Recovery on July 24, 2020 at $7.70. Since then the stock has had a nice run and I sold my position today at $8.50 for a 10.3% gain. The technical indicators are still flashing a buy for Energy Recovery. But the stock has had a sharp run-up. The MACD also had a bearish crossover and that was partly the reason for my sell. The Relative Strength Index was at 63 today and I did not wish for it be in the over bought territory before I sold this position. 

Exhibit: Energy Recovery Technical Indicators on August 11, 2020.

 (Source: Tradingview)

I took a position in Redfin on August 10, 2020 at a price of $41.80. I never had full conviction for this trade. I felt Redfin (NASDAQ: RDFN) was too overvalued and there were too many uncertainties in the economy and in the housing market. Given the loss of unemployment benefits for millions of Americans, I wasn't sure how this was going to impact the demand for housing. The Federal Reserve has done an admirable job of lowering the interest rates and stabilizing the financial markets. But even they cannot create jobs or pay unemployment benefits or prevent evictions. So, I felt that the economy is in a very precarious position.  In this current situation, I did not want own a company like Redfin. It may be a speculative bet at these valuations and economic conditions. I sold Redfin at $43.50 for total gain of 4%.   

 

     

     

Is Redfin a buy at $41.80?

Redfin (NASDAQ: RDFN)  - the real estate brokerage company - had a great Q2 2020. Revenue increased by 8% y-o-y to $214 million. The company did book a $4 million operating loss but that was down from $12 million in the same quarter in 2019. The ultra low mortgage rates are benefiting the company. But given the pace of home sales there's very low levels of available homes for sale.The company has provided good guidance for the third quarter. 

Exhibit: Redfin had a down day today, but the stock may not have hit bottom

 

(Source: Tradingview)

There could be support for the stock at around the $41 level.  If the stock drops below the support level at $39, that may be a very bearish sign for the short-term. On the upside there could be resistance for the stock at $43.65. My limit order got triggered today at $41.80 and it ended the day at $41.70. If it passes $43.65 it could go to new all-time highs. Majority of the Wall Street analysts are neutral on the stock with a target of $39.50.

(Disclosure: I own Redfin)   

     

A 6% return on Caterpillar in 6 days

I bought Caterpillar (NYSE: CAT) at $131.60 on August 4, 2020. I had visualized my trade in a previous blog post on this stock. I had placed a limit order at $139.97 or just below the $140. The limit got triggered today for a return of 6.3% in six days. My rational was that the stock could face some resistance just about $140 and wanted to exit my position at that level.  

Exhibit: Caterpillar trade set-up between August 4 and August 10, 2020 

 (Source: TradingView)